关注
Wouter Zandee
Wouter Zandee
UMCG
在 erasmusmc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
EA Carlsen, N Fazio, D Granberg, S Grozinsky-Glasberg, ...
Endocrine-related cancer 26 (2), 227-239, 2019
1512019
Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors
WT Zandee, T Brabander, A Blažević, BLR Kam, JJM Teunissen, ...
The Journal of Clinical Endocrinology & Metabolism 104 (4), 1336-1344, 2019
1262019
Role of biomarker tests for diagnosis of neuroendocrine tumours
J Hofland, WT Zandee, WW de Herder
Nature Reviews Endocrinology 14 (11), 656-669, 2018
1242018
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study
G Rindi, C Klersy, L Albarello, E Baudin, A Bianchi, MW Buchler, M Caplin, ...
Neuroendocrinology 107 (4), 375-386, 2019
922019
Management of carcinoid syndrome: a systematic review and meta-analysis
J Hofland, AD Herrera-Martínez, WT Zandee, WW de Herder
Endocrine-Related Cancer 26 (3), R145-R156, 2019
742019
The evolution of neuroendocrine tumor treatment reflected by ENETS guidelines
WT Zandee, WW de Herder
Neuroendocrinology 106 (4), 357-365, 2018
742018
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
WT Zandee, RA Feelders, DA Smit Duijzentkunst, J Hofland, ...
European Journal of Endocrinology 181 (1), 45-53, 2019
672019
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
WT Zandee, K Kamp, RC van Adrichem, RA Feelders, WW de Herder
Endocrine-Related Cancer 24 (7), R261-R274, 2017
652017
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours
WT Zandee, K Kamp, RCS van Adrichem, RA Feelders, WW de Herder
European Journal of Endocrinology 175 (5), 361-366, 2016
592016
Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours
A Blažević, WT Zandee, GJH Franssen, J Hofland, MLF van Velthuysen, ...
Endocrine-Related Cancer 25 (3), 245-254, 2018
472018
Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines
HHG Verbeek, JAA Meijer, WT Zandee, KH Kramp, WJ Sluiter, JW Smit, ...
Annals of Surgical Oncology 22, 1207-1213, 2015
292015
Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
WT Zandee, T Brabander, A Blažević, NS Minczeles, RA Feelders, ...
The Journal of Clinical Endocrinology & Metabolism 106 (9), e3665-e3672, 2021
262021
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is≥ 10%?
E Merola, T Alonso Gordoa, P Zhang, T Al‐Toubah, E Pellè, ...
The Oncologist 26 (4), 294-301, 2021
252021
Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours
WT Zandee, RC van Adrichem, K Kamp, RA Feelders, ...
Clinical Endocrinology 87 (2), 165-170, 2017
252017
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs
L de Mestier, A Lamarca, J Hernando, W Zandee, T Alonso-Gordoa, ...
Endocrine-Related Cancer 28 (8), 549-561, 2021
232021
Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging
J Refardt, WT Zandee, T Brabander, RA Feelders, GJH Franssen, ...
Endocrine-related cancer 27 (11), 615-624, 2020
212020
A retrospective analysis of the diagnostic performance of 11C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant …
ME Noltes, S Kruijff, L Jansen, HE Westerlaan, WT Zandee, R Dierckx, ...
EJNMMI research 11, 1-9, 2021
172021
Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework
LD de Hosson, LM van Veenendaal, Y Schuller, WT Zandee, ...
Annals of Oncology 28 (12), 3022-3027, 2017
172017
Evolution of the mesenteric mass in small intestinal neuroendocrine tumours
A Blažević, T Brabander, WT Zandee, J Hofland, GJH Franssen, ...
Cancers 13 (3), 443, 2021
142021
Initiating pancreatic neuroendocrine tumor (pNET) screening in young MEN1 patients: results from the DutchMEN study group
MJ Klein Haneveld, MJC van Treijen, CRC Pieterman, OM Dekkers, ...
The Journal of Clinical Endocrinology & Metabolism 106 (12), 3515-3525, 2021
132021
系统目前无法执行此操作,请稍后再试。
文章 1–20